News

Researchers have discovered a way to modify the message containing the instruction for CFTR, forcing the protein-making machinery to skip over this “stop sign” mutation, which allows a functional version of the protein to be made.

A study has characterized the evolution of the Omicron variant of SARS-CoV-2, establishing that Omicron is the result of adaptive evolution rather than recombination of previous variants.

A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies, according to a new study in the journal npj Vaccines.

A research team has re-analyzed all public RNA sequencing data to uncover almost ten times more RNA viruses than were previously known, including several new species of coronaviruses.

A new study has adopted a multi-omics methodology to explore potential links between diet, the microbiome and the immune response in multiple sclerosis (MS). The results are published in EBioMedicine.

Using CRISPR-Cas9 gene-editing technology, researchers have deleted a key gene encoding a protein found in Anopheles gambiae mosquitoes which could prevent the transmission of malaria from mosquitoes to humans.

A new report found that all combinations of primary and booster COVID-19 vaccines granted Emergency Use Authorization or approval by the Food and Drug Administration are safe and result in an immune response against SARS-CoV-2.

Researchers have developed a range of permanent hair dyes that avoid the allergenic properties of traditional formulations.

According to new data from the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, nearly fifty percent of blood cancer patients do not have enough antibodies able to neutralize Omicron after a third vaccine dose.

A study has shown that transfusions of blood plasma donated by people who have already recovered from COVID-19 infection may help other hospitalized patients.